Prospects for Leveraging the Microbiota as Medicine for Hypertension

Affiliations

• ¹ Department of Integrative Physiology and Anesthesiology, Baylor College of Medicine, Houston, TX (D.J.D.).
• ² Center for Hypertension and Precision Medicine, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).
• ³ Microbiome Consortium, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).
• ⁴ Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).
• ⁵ Hypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia (R.R.M., F.Z.M.).
• ⁶ Victorian Heart Institute, Monash University, Melbourne, Australia (R.R.M., F.Z.M.).
• ⁷ Baker Heart and Diabetes Institute, Melbourne, Australia (R.R.M., F.Z.M.).
• ⁸ Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, PR China (H.-B.L., Y.L.).
• ⁹ Department of Physiology, Medical College of Georgia at Augusta University (J.M.A.-B.).
• ¹⁰ Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD (J.L.P.).
• ¹¹ Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (D.N.M.).
• ¹² Experimental and Clinical Research Center, a cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Germany (D.N.M.).
• ¹³ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany (D.N.M.).
• ¹⁴ DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany (D.N.M.).